Zdrowie i gospodarka · 19/12/1997

FDA Revokes Regulation on PET Drug Products

The US Food and Drug Administration (FDA) is revoking a regulation on positron emission tomography (PET) radiopharmaceutical drug products, allowing manufacturers to request exceptions to current good manufacturing practice (CGMP) regulations. This action is in line with the provisions of the Food and Drug Administration Modernization Act of 1997.